从实验室到床边的桥梁:肿瘤学转化研究的演变和影响。意大利肿瘤临床组织(GOIRC)的经验。

IF 2 4区 医学 Q3 ONCOLOGY Tumori Pub Date : 2024-12-15 DOI:10.1177/03008916241302919
Benedetta Pellegrino, Filippo Giovanardi, Carmelo Tibaldi, Luca Moscetti, Andrea Vingiani, Luana Calabrò, Gabriele Zoppoli, Stefania Didone, Lorenzo Ferrando, Enrico Franceschi, Renata Todeschini, Michele Tognetto, Alessandro Leonetti, Roberta Minari, Chiara Tommasi, Olga Serra, Luca Boni, Giancarlo Pruneri, Antonino Musolino
{"title":"从实验室到床边的桥梁:肿瘤学转化研究的演变和影响。意大利肿瘤临床组织(GOIRC)的经验。","authors":"Benedetta Pellegrino, Filippo Giovanardi, Carmelo Tibaldi, Luca Moscetti, Andrea Vingiani, Luana Calabrò, Gabriele Zoppoli, Stefania Didone, Lorenzo Ferrando, Enrico Franceschi, Renata Todeschini, Michele Tognetto, Alessandro Leonetti, Roberta Minari, Chiara Tommasi, Olga Serra, Luca Boni, Giancarlo Pruneri, Antonino Musolino","doi":"10.1177/03008916241302919","DOIUrl":null,"url":null,"abstract":"<p><p>The Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) is Italy's first cooperative oncology research group, evolving to conduct academic clinical trials since 1985. With 167 publications and collaborations with national and international partners, GOIRC has significantly impacted clinical practices. The group emphasizes training and has developed robust internal standard operative procedures (SOPs) to enhance data quality. GOIRC is poised to tackle future challenges in translational research, focusing on innovative trial designs, precision medicine, and leveraging different laboratory resources across its 42 units.</p>","PeriodicalId":23349,"journal":{"name":"Tumori","volume":" ","pages":"3008916241302919"},"PeriodicalIF":2.0000,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC).\",\"authors\":\"Benedetta Pellegrino, Filippo Giovanardi, Carmelo Tibaldi, Luca Moscetti, Andrea Vingiani, Luana Calabrò, Gabriele Zoppoli, Stefania Didone, Lorenzo Ferrando, Enrico Franceschi, Renata Todeschini, Michele Tognetto, Alessandro Leonetti, Roberta Minari, Chiara Tommasi, Olga Serra, Luca Boni, Giancarlo Pruneri, Antonino Musolino\",\"doi\":\"10.1177/03008916241302919\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) is Italy's first cooperative oncology research group, evolving to conduct academic clinical trials since 1985. With 167 publications and collaborations with national and international partners, GOIRC has significantly impacted clinical practices. The group emphasizes training and has developed robust internal standard operative procedures (SOPs) to enhance data quality. GOIRC is poised to tackle future challenges in translational research, focusing on innovative trial designs, precision medicine, and leveraging different laboratory resources across its 42 units.</p>\",\"PeriodicalId\":23349,\"journal\":{\"name\":\"Tumori\",\"volume\":\" \",\"pages\":\"3008916241302919\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tumori\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/03008916241302919\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumori","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03008916241302919","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

Gruppo oncology Italiano di Ricerca Clinica (GOIRC)是意大利第一个合作肿瘤学研究小组,自1985年以来一直开展学术临床试验。GOIRC发表了167篇文章,并与国家和国际合作伙伴开展了合作,对临床实践产生了重大影响。该集团强调培训,并制定了强有力的内部标准操作程序(SOPs),以提高数据质量。GOIRC准备应对未来在转化研究方面的挑战,专注于创新试验设计、精准医学,并在其42个单位中利用不同的实验室资源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC).

The Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) is Italy's first cooperative oncology research group, evolving to conduct academic clinical trials since 1985. With 167 publications and collaborations with national and international partners, GOIRC has significantly impacted clinical practices. The group emphasizes training and has developed robust internal standard operative procedures (SOPs) to enhance data quality. GOIRC is poised to tackle future challenges in translational research, focusing on innovative trial designs, precision medicine, and leveraging different laboratory resources across its 42 units.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Tumori
Tumori 医学-肿瘤学
CiteScore
3.50
自引率
0.00%
发文量
58
审稿时长
6 months
期刊介绍: Tumori Journal covers all aspects of cancer science and clinical practice with a strong focus on prevention, translational medicine and clinically relevant reports. We invite the publication of randomized trials and reports on large, consecutive patient series that investigate the real impact of new techniques, drugs and devices inday-to-day clinical practice.
期刊最新文献
Clinical difference between solitary and multiple pulmonary adenocarcinoma nodules. MLH1 promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of MLH1 gene? Efficacy and safety of PD-1 inhibitor plus chemotherapy in advanced nasopharyngeal carcinoma: A meta-analysis. Factors influencing the colorectal surveillance adherence in Lynch Syndrome: A retrospective monocentric study. Implications and mechanisms of O-GlcNAcylation in cancer therapy resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1